Koda Y - Search Results

1

Synthesis, antifungal, haemolytic and cytotoxic activities of a series of bis(alkylpyridinium)alkanes.

Obando D, Pantarat N, Handke R, Koda Y, Widmer F, Djordjevic JT, Ellis DH, Sorrell TC, Jolliffe KA. Obando D, et al. Among authors: koda y. Bioorg Med Chem. 2009 Sep 1;17(17):6329-39. doi: 10.1016/j.bmc.2009.07.037. Epub 2009 Jul 23. Bioorg Med Chem. 2009. PMID: 19665385

2

Synthesis and Evaluation of a Series of Bis(pentylpyridinium) Compounds as Antifungal Agents.

Obando D, Koda Y, Pantarat N, Lev S, Zuo X, Bijosono Oei J, Widmer F, Djordjevic JT, Sorrell TC, Jolliffe KA. Obando D, et al. Among authors: koda y. ChemMedChem. 2018 Jul 18;13(14):1421-1436. doi: 10.1002/cmdc.201800331. Epub 2018 Jun 19. ChemMedChem. 2018. PMID: 29781143

3

Caco-2 cell permeability and stability of two d-glucopyranuronamide conjugates of thyrotropin-releasing hormone.

Wessling ST, Ross BP, Koda Y, Blanchfield JT, Toth I. Wessling ST, et al. Among authors: koda y. Bioorg Med Chem. 2007 Jul 15;15(14):4946-50. doi: 10.1016/j.bmc.2007.04.042. Epub 2007 Apr 29. Bioorg Med Chem. 2007. PMID: 17498958

4

Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

Koda Y, Del Borgo M, Wessling ST, Lazarus LH, Okada Y, Toth I, Blanchfield JT. Koda Y, et al. Bioorg Med Chem. 2008 Jun 1;16(11):6286-96. doi: 10.1016/j.bmc.2008.04.020. Epub 2008 Apr 15. Bioorg Med Chem. 2008. PMID: 18468445 Free PMC article.

5

Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors.

Koda Y, Kikuzato K, Mikuni J, Tanaka A, Yuki H, Honma T, Tomabechi Y, Kukimoto-Niino M, Shirouzu M, Shirai F, Koyama H. Koda Y, et al. Bioorg Med Chem Lett. 2017 Nov 15;27(22):4994-4998. doi: 10.1016/j.bmcl.2017.10.012. Epub 2017 Oct 7. Bioorg Med Chem Lett. 2017. PMID: 29037944

6

Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide.

Koda Y, Shiotani K, Toth I, Tsuda Y, Okada Y, Blanchfield JT. Koda Y, et al. Bioorg Med Chem Lett. 2007 Apr 1;17(7):2043-6. doi: 10.1016/j.bmcl.2007.01.051. Epub 2007 Jan 25. Bioorg Med Chem Lett. 2007. PMID: 17300932

7

Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.

Yuki H, Kikuzato K, Koda Y, Mikuni J, Tomabechi Y, Kukimoto-Niino M, Tanaka A, Shirai F, Shirouzu M, Koyama H, Honma T. Yuki H, et al. Among authors: koda y. Bioorg Med Chem. 2017 Aug 15;25(16):4259-4264. doi: 10.1016/j.bmc.2017.05.053. Epub 2017 Jun 16. Bioorg Med Chem. 2017. PMID: 28662963

8

Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the caco-2 cell monolayer system.

Wu S, Campbell C, Koda Y, Blanchfield JT, Toth I. Wu S, et al. Among authors: koda y. Med Chem. 2006 Mar;2(2):203-11. doi: 10.2174/157340606776056205. Med Chem. 2006. PMID: 16787368

9

Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.

Kim IH, Nishi K, Tsai HJ, Bradford T, Koda Y, Watanabe T, Morisseau C, Blanchfield J, Toth I, Hammock BD. Kim IH, et al. Among authors: koda y. Bioorg Med Chem. 2007 Jan 1;15(1):312-23. doi: 10.1016/j.bmc.2006.09.057. Epub 2006 Sep 29. Bioorg Med Chem. 2007. PMID: 17046265 Free PMC article.

10

In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue.

Koda Y, Liang MT, Blanchfield JT, Toth I. Koda Y, et al. Int J Pharm. 2008 May 22;356(1-2):37-43. doi: 10.1016/j.ijpharm.2007.12.036. Epub 2008 Jan 4. Int J Pharm. 2008. PMID: 18272306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters